A detailed history of Rossmore Private Capital transactions in Eli Lilly & CO stock. As of the latest transaction made, Rossmore Private Capital holds 19,148 shares of LLY stock, worth $14.7 Million. This represents 2.11% of its overall portfolio holdings.

Number of Shares
19,148
Previous 19,114 0.18%
Holding current value
$14.7 Million
Previous $17.3 Million 1.98%
% of portfolio
2.11%
Previous 2.28%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$772.14 - $960.02 $26,252 - $32,640
34 Added 0.18%
19,148 $17 Million
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $260,228 - $326,345
359 Added 1.91%
19,114 $17.3 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $802,431 - $1.07 Million
1,355 Added 7.79%
18,755 $14.6 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $42,015 - $49,530
80 Added 0.46%
17,400 $10.1 Million
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $25,212 - $34,759
-58 Reduced 0.33%
17,320 $9.3 Million
Q2 2023

Aug 11, 2023

SELL
$350.74 - $468.98 $12,275 - $16,414
-35 Reduced 0.2%
17,378 $8.15 Million
Q1 2023

May 02, 2023

BUY
$310.63 - $364.82 $77,657 - $91,205
250 Added 1.46%
17,413 $5.98 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $5,144 - $5,994
16 Added 0.09%
17,163 $6.28 Million
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $13,341 - $15,204
45 Added 0.26%
17,147 $5.54 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $69,682 - $81,817
250 Added 1.48%
17,102 $5.55 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $118,049 - $146,704
503 Added 3.08%
16,852 $4.83 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $14,615 - $18,137
65 Added 0.4%
16,349 $4.52 Million
Q3 2021

Nov 08, 2021

SELL
$221.6 - $272.71 $42,325 - $52,087
-191 Reduced 1.16%
16,284 $3.76 Million
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $54,345 - $70,295
301 Added 1.86%
16,475 $3.78 Million
Q1 2021

May 10, 2021

BUY
$164.32 - $212.72 $261,926 - $339,075
1,594 Added 10.93%
16,174 $3.02 Million
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $27,005 - $35,734
207 Added 1.44%
14,580 $2.46 Million
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $375,054 - $433,818
2,565 Added 21.72%
14,373 $2.13 Million
Q2 2020

Aug 05, 2020

BUY
$136.42 - $164.18 $206,267 - $248,240
1,512 Added 14.69%
11,808 $1.94 Million
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $9,643 - $11,935
81 Added 0.79%
10,296 $1.43 Million
Q3 2019

Nov 05, 2019

BUY
$106.79 - $116.16 $299,012 - $325,248
2,800 Added 37.76%
10,215 $1.14 Million
Q1 2019

Apr 30, 2019

BUY
$111.31 - $131.02 $33,393 - $39,306
300 Added 4.22%
7,415 $962,000
Q3 2018

Oct 26, 2018

BUY
$85.86 - $107.31 $192,755 - $240,910
2,245 Added 46.1%
7,115 $764,000
Q2 2018

Jul 20, 2018

BUY
$75.7 - $86.88 $368,659 - $423,105
4,870 New
4,870 $416,000
Q1 2018

May 04, 2018

SELL
$74.21 - $87.6 $95,656 - $112,916
-1,289 Closed
0 $0
Q4 2017

Mar 15, 2018

BUY
$81.94 - $87.89 $105,620 - $113,290
1,289
1,289 $109 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rossmore Private Capital Portfolio

Follow Rossmore Private Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rossmore Private Capital, based on Form 13F filings with the SEC.

News

Stay updated on Rossmore Private Capital with notifications on news.